Published in Nat Med on April 01, 1995
Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol (2006) 1.47
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model (2008) 1.35
"Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des (2012) 1.31
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther (2012) 1.19
The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry (2011) 1.08
Pharmacogenetics of alcohol and alcohol dependence treatment. Curr Pharm Des (2010) 1.05
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART). Postgrad Med (2009) 0.90
Genetic influences on smoking: candidate genes. Environ Health Perspect (1998) 0.86
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)? J Addict Res Ther (2015) 0.85
Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. J Genet Syndr Gene Ther (2011) 0.83
Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. Med Hypotheses (2014) 0.78
The pharmacogenetics of alcohol use disorder. Alcohol Clin Exp Res (2015) 0.78
Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms. J Reward Defic Syndr (2015) 0.78
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? Mol Neurobiol (2015) 0.78
The dopamine system and alcohol dependence. Shanghai Arch Psychiatry (2014) 0.77
Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2). Brain Imaging Behav (2015) 0.76
Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet (2015) 0.76
Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study. J Psychoactive Drugs (2013) 0.76
Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality. Clin Med Rev Case Rep (2015) 0.75
Bromocriptine in the treatment of alcoholics. Nat Med (1995) 0.75
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr (2015) 0.75
Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain. Life Sci (1967) 2.84
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry (1991) 2.30
Rapid and sensitive pollutant detection by induction of heat shock gene-bioluminescence gene fusions. Appl Environ Microbiol (1994) 1.97
Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J Virol (1999) 1.84
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72
Effectiveness of out-of-hours biochemistry investigations. Br Med J (Clin Res Ed) (1981) 1.53
Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc (1992) 1.51
Cognition in Parkinson disease: an event-related potential perspective. Ann Neurol (1982) 1.46
DRD2 gene and alcoholism. Science (1998) 1.43
D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses (1994) 1.42
The sobering D2 story. Science (1994) 1.39
Screening for hyperlipidaemia in diabetics. Ann Clin Biochem (1992) 1.38
GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex. Antioxid Redox Signal (2001) 1.36
Electrocortical signs of levels of processing: perceptual analysis and recognition memory. Psychophysiology (1980) 1.31
D2 dopamine receptor gene and obesity. Int J Eat Disord (1994) 1.30
Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology (1980) 1.29
Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend (1993) 1.27
A fatal thrombotic disorder associated with an acquired inhibitor of protein C. N Engl J Med (1987) 1.25
Myxoedema revealed by simvastatin induced myopathy. BMJ (1994) 1.24
Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain (1993) 1.19
Surgical treatment of adult primary hepatic sarcoma. Br J Surg (2000) 1.13
No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA (1994) 1.12
Clinical outcomes assessment in multiple sclerosis. Ann Neurol (1996) 1.11
The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet (2000) 1.10
Multiple mRNAs from rat kidney and brain encode a single Na+,K+-ATPase beta subunit protein. J Biol Chem (1987) 1.09
Brain wave components of the contingent negative variation in humans. Science (1976) 1.07
Sexual behavior and aggression in male mice: involvement of the vomeronasal system. J Neurosci (1984) 1.06
Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. Addict Behav (2004) 1.06
Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol (1992) 1.05
P3 in young boys as a predictor of adolescent substance use. Alcohol (1993) 1.04
Tissue distribution of mRNAs encoding the alpha isoforms and beta subunit of rat Na+,K+-ATPase. Biochem Biophys Res Commun (1987) 1.04
The maturation of rat brain myelin. Lipids (1968) 1.02
Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers. Alcohol (1997) 1.02
Alcohol consumption and cognitive functioning in social drinkers. J Stud Alcohol (1977) 1.02
Relationship between neuropsychological performance and alcohol consumption in alcoholics. Biol Psychiatry (1978) 1.01
Genetic mapping of mutations using phenotypic pools and mapped RAPD markers. Nucleic Acids Res (1993) 1.01
Human neurologic function and the aging process. J Am Geriatr Soc (1980) 1.00
Harmful drinking in military veterans with post-traumatic stress disorder: association with the D2 dopamine receptor A1 allele. Alcohol Alcohol (2002) 1.00
Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues. J Med Chem (1996) 1.00
D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol (1994) 0.99
D2 dopamine receptor and GABA(A) receptor beta3 subunit genes and alcoholism. Psychiatry Res (1998) 0.99
Palinopsia reconsidered. Neurology (1982) 0.99
Alcohol and the disruption of cognitive processes. Arch Gen Psychiatry (1974) 0.98
Acute transient hypokalaemia: new interpretation of a common event. Lancet (1982) 0.98
Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele. Behav Genet (1995) 0.98
Neuropsychologic decrements as a function of alcohol intake in male students. Alcohol Clin Exp Res (1980) 0.96
A novel function for the Xslug gene: control of dorsal mesendoderm development by repressing BMP-4. Mech Dev (2000) 0.95
D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence. Eur Psychiatry (2002) 0.94
Inhibition of enzymatic synthesis of epinephrine by low doses of glucocorticoids. Endocrinology (1967) 0.94
Detection of basic organic drugs and their metabolites in urine. Clin Chem (1970) 0.93
Maritally distressed women with alcohol problems: the impact of a short-term alcohol-focused intervention on drinking behaviour and marital satisfaction. Addiction (2000) 0.92
Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. Alcohol (1993) 0.92
Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr (1994) 0.92
GABA(A) receptor beta 3 subunit gene and psychiatric morbidity in a post-traumatic stress disorder population. Psychiatry Res (2001) 0.90
Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group. Ann Neurol (1994) 0.90
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. Neurology (1989) 0.89
Pheromonally induced release of luteinizing hormone in male mice: involvement of the vomeronasal system. J Neurosci (1984) 0.89
Protein and ribonucleic acid metabolism in brains of mice following chronic alcohol consumption. Ann N Y Acad Sci (1973) 0.89
Long-latency event-related potentials in normal aging and dementia. Adv Neurol (1982) 0.89
Alcoholism. Ann Intern Med (1984) 0.88
Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch Neurol (1990) 0.88
Visual evoked potentials and long latency event-related potentials in chronic renal failure. Neurology (1983) 0.88
Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.87
Human neuro-specimen banking 1961-1992. The National Neurological Research Specimen Bank (a donor program of pre- and post-mortem tissues and cerebrospinal fluid/blood; and a collection of cryopreserved human neurological specimens for neuroscientists). J Neural Transm Suppl (1993) 0.86
The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. Behav Genet (1997) 0.86
Hypogammaglobulinemia in asthmatic patients. Ann Allergy (1992) 0.85
[3H]naloxone binding in the human brain: alcoholism and the TaqI A D2 dopamine receptor polymorphism. Brain Res (1996) 0.85
Cognitive function in old and very old residents of a residential facility: relationship to age, education, and dementia. J Am Geriatr Soc (1994) 0.85
HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association. Eur Psychiatry (2010) 0.85
Out-of-hours chemical pathology. Lancet (1985) 0.85
Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia. Eur Psychiatry (2010) 0.85
Pathogenicity of L forms of Staphylococcus aureus. Am J Clin Pathol (1967) 0.85
The basis of intra-blood-brain-barrier IgG synthesis. Ann Neurol (1985) 0.84
Helping the female partners of men abusing alcohol: a comparison of three treatments. Addiction (2001) 0.84
Extraversion. Interaction between D2 dopamine receptor polymorphisms and parental alcoholism. Alcohol (2000) 0.84
Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics (1991) 0.84
Alcohol and affect in dyadic social interaction. Psychosom Med (1975) 0.83
Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids. Neurology (1980) 0.83
Circadian variation of serum leptin in healthy and diabetic men. Chronobiol Int (2001) 0.83
Prenatal alcohol exposure alters adult expression of sexually dimorphic behavior in the rat. Science (1984) 0.83
Localization and characterization of members of a family of repetitive sequences in the goat beta globin locus. Nucleic Acids Res (1985) 0.83
Gender stereotypes and drinking cognitions as indicators of moderate and high risk drinking among young women and men. Drug Alcohol Depend (2001) 0.82
Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet (1994) 0.82
Drinking restraint versus alcohol expectancies: which is the better indicator of alcohol problems? J Stud Alcohol (2000) 0.82
The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J Neuroimmunol (1988) 0.82